AORT

Artivion, Inc.

20.23 USD
-0.04 (-0.20%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Artivion, Inc. stock is up 20.2% since 30 days ago. The next earnings date is May 2, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 51.61% of the previous 31 February’s closed higher than January. 100% of analysts rate it a buy.

About Artivion, Inc.

Artivion Inc. manufactures, processes, and distributes medical devices and implantable human tissues worldwide. The company offers BioGlue, a polymer consisting of bovine blood protein and an agent for cross-linking proteins. It also provides E-xtra design engineering systems for the treatment of aortic vascular diseases.

  • Stifel
    Fri Feb 16, 10:03
    buy
    confirm
  • Needham
    Fri Feb 16, 05:43
    buy
    confirm